NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/04/2024
Voltar para busca
Dado oficial do USPTO
ONCOREVEAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ONCOREVEAL
ST13
US500000090980823Classe
1, 5, 9
Pedido
90980823
Registro
7347499
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
58
Atualização mais recente
02/04/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
17/02/2021
Data de registro
02/04/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/04/2024
Última transação
02/04/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
16/03/2022
Primeiro uso no comércio
16/03/2022
Código do desenho
4
Tipo de titular
03
Localização do titular
Natick, MA, US
Examinador
CLYBURN, CARLA DIONNE
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Pillar Biosciences, Inc.
Representantes
Andrew T. Pettit PERKINS COIE LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagents and reagent kits comprising nucleic acidsnaturally occurring and modified nucleotidesenzymesbuffersall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationstranscriptionsexpressionswith the aforementioned reagents and reagent kits being in the fields of scientific researchclinical researchscientific diagnostics research; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for scientific researchclinical researchscientific diagnostics research; biological and biochemical kits for scientific researchclinical researchscientific diagnostics research
Classe 5
Reagents and reagent kits comprising nucleic acidsnaturally occurring and modified nucleotidesenzymesbuffersall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationstranscriptionsexpressionswith the aforementioned reagents and reagent kits being for medical diagnostic purposes; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for medical diagnostic purposes; biological and biochemical kits comprised of diagnostic preparations for medical purposesfor the diagnosis and treatment of cancer; biological and biochemical kits for medical diagnostic purposes
Classe 9
Downloadable computer software for the collectionmanagementanalysis of data for use in the fields of scientific researchclinical researchscientific diagnosticsmedical diagnostics; downloadable computer software for analyzing biological samples; downloadable computer software for analyzing biological samples for medical purposesfor the diagnosis and treatment of cancer; downloadable computer software for use with reagents and reagent kitsall for the purpose of detectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsall in the fields of scientific researchclinical researchscientific diagnostics researchmedical diagnostics; downloadable computer software for bioinformatics and gene expression microarray image analysisgene expression quantificationgene image processinggene information processing; downloadable computer software for health and wellness assessmentfor use in genomic analysis; downloadable computer software for genetic and bioinformatics analysis
Publicações
Histórico de despachos e eventos da marca no USPTO.
58 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
24/02/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23/02/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
06/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/01/2024
DRRR
DIVISIONAL REQUEST RECEIVED
30/01/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
30/01/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
30/10/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
30/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
31/07/2023
GNRT
NON-FINAL ACTION E-MAILED
31/07/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
31/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/07/2023
ALIE
ASSIGNED TO LIE
07/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/03/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/09/2022
GNRT
NON-FINAL ACTION E-MAILED
08/09/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/08/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/08/2022
EX1G
SOU EXTENSION 1 GRANTED
10/08/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/08/2022
IUAF
USE AMENDMENT FILED
01/08/2022
EXT1
SOU EXTENSION 1 FILED
01/08/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/08/2022
EISU
TEAS STATEMENT OF USE RECEIVED
01/08/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/02/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2021
PUBO
PUBLISHED FOR OPPOSITION
07/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
01/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
01/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/11/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
29/10/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
19/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/09/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/09/2021
GNRT
NON-FINAL ACTION E-MAILED
21/09/2021
CNRT
NON-FINAL ACTION WRITTEN
21/09/2021
DOCK
ASSIGNED TO EXAMINER
11/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/05/2021
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
23/02/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
23/02/2021
NWAP
NEW APPLICATION ENTERED
20/02/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ONCOREVEAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.